Back
BNY Mellon High Yield Strategies Fund Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Buy
51
DHF
BNY Mellon High Yield Strategies Fund
Last Price:
$2.48
Seasonality Move:
2.42%
Buy
67
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$591.74
Seasonality Move:
15.11%
Buy
51
BNY Mellon High Yield Strategies Fund (DHF)
is a Buy
Is BNY Mellon High Yield Strategies Fund a Buy, Sell or Hold?
-
The current BNY Mellon High Yield Strategies Fund [DHF] share price is $2.48. The Score for DHF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
DHF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $591.02. The Score for MDGL is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DHF Stock Price Chart
What is BNY Mellon High Yield Strategies Fund's stock price today?
-
The BNY Mellon High Yield Strategies Fund share price today is $2.48The current trend is relatively stagnant and DHF is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $591.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
DHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 40.08 | Sell |
| Chaikin Money Flow: | 208697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.49 - 2.53) | Sell |
| Bollinger Bands (100): | (2.52 - 2.6) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.54 | Buy |
| Relative Strength Index (14 RSI): | 63.09 | Buy |
| Chaikin Money Flow: | 850060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (548.18 - 585.88) | Buy |
| Bollinger Bands (100): | (384.94 - 533.12) | Buy |
DHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.5 | Sell |
| 20-day SMA: | 2.51 | Sell |
| 50-day SMA: | 2.54 | Sell |
| 200-day SMA: | 2.54 | Sell |
| 8-day EMA: | 2.49 | Sell |
| 20-day EMA: | 2.51 | Sell |
| 50-day EMA: | 2.53 | Sell |
| 200-day EMA: | 2.54 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 561.5 | Buy |
| 20-day SMA: | 571.82 | Buy |
| 50-day SMA: | 508.82 | Buy |
| 200-day SMA: | 382.95 | Buy |
| 8-day EMA: | 564.29 | Buy |
| 20-day EMA: | 558.29 | Buy |
| 50-day EMA: | 520.52 | Buy |
| 200-day EMA: | 411.49 | Buy |
BNY Mellon High Yield Strategies Fund Earnings Growth & DHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.33 per share, and an increase next year of $13.64 per share.
BNY Mellon High Yield Strategies Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||